1185 ELTROMBOPAG IN CHRONIC LIVER DISEASE PATIENTS WITH THROMBOCYTOPENIA UNDERGOING AN ELECTIVE INVASIVE PROCEDURE: RESULTS FROM ELEVATE, A RANDOMISED CLINICAL TRIAL

1185 ELTROMBOPAG IN CHRONIC LIVER DISEASE PATIENTS WITH THROMBOCYTOPENIA UNDERGOING AN ELECTIVE INVASIVE PROCEDURE: RESULTS FROM ELEVATE, A RANDOMISED CLINICAL TRIAL N. Afdhal, E. Giannini, G.N. Tayyab, A. Mohsin, J.W. Lee, A. Andriulli, L. Jeffers, J. McHutchison, F. Campbell, N. Blackman, D. Hyde, A. Brainsky, D. Theodore. Division of Gastroenterology/Liver Center, Beth Israel Deaconess Medical Center, Boston, MA, USA; Gastroenterology Unit, Department of Internal Medicine, University of Genoa, Genoa, Italy; Department of Medicine/Gastroenterology & Hepatology, Post Graduate Medical Institute & Lahore General Hospital, Department of Gastroenterology, Services Hospital Lahore, Services Institute of Medical Sciences, Lahore, Pakistan; Department of Internal Medicine, Inha University Hospital and School of Medicine, Incheon, Republic of Korea; Department of Internal Medicine Division of Gastroenterology, Casa Sollievo Sofferenza Hospital, San Giovanni Rotondo, Italy; Center for Liver Diseases, University of Miami, Miller School of Medicine, Miami, FL, Division of Gastroenterology, Duke University Medical Center, Durham, NC, USA; Clinical Development, GlaxoSmithKline, Stockley Park, Uxbridge, UK; Biometrics and Epidemiology, Clinical Development, GlaxoSmithKline, Collegeville, PA, Clinical Development, GlaxoSmithKline, Research Triangle Park, NC, USA E-mail: nafdhal@bidmc.harvard.edu